E
Agenus Inc. AGEN
$3.70 $0.236.63% NASDAQ
Recommendation
Prev Close
$3.47
Volume
955,215
Avg Vol (90D)
506,342
Market Cap
$118.01M
Dividend & Yield
--
52-Week Range
$1.38 - $7.34
P/E (TTM)
--
EPS (TTM)
-$2.10
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Agenus (AGEN, $3.47) Stochastic Oscillator left the oversold zone on January 06, 2026
1/7/2026 - Tickeron - Technical Analysis
Agenus (AGEN, $3.47) entered Uptrend as Momentum indicator ascends above 0 level on Jan 06, 2026
1/7/2026 - Tickeron - Technical Analysis
Agenus (AGEN, $3.47) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 6, 2026
1/7/2026 - Tickeron - Technical Analysis
Agenus (AGEN) Q3 2024 Earnings Call Transcript
1/5/2026 - Nasdaq News: Markets
Agenus (AGEN) Q3 2024 Earnings Call Transcript
1/5/2026 - Fool.com Headlines
Agenus (AGEN) Q1 2025 Earnings Call Transcript
1/5/2026 - Nasdaq News: Markets
Agenus (AGEN) Q4 2024 Earnings Call Transcript
1/5/2026 - Nasdaq News: Markets
Agenus (AGEN) Q1 2025 Earnings Call Transcript
1/5/2026 - Fool.com Headlines
Agenus (AGEN) Q4 2024 Earnings Call Transcript
1/5/2026 - Fool.com Headlines
Agenus (AGEN, $3.23) RSI Indicator left the oversold zone on January 02, 2026
1/3/2026 - Tickeron - Technical Analysis
Agenus (AGEN, $3.14) Aroon Indicator entered a Downtrend on December 31, 2025.
1/1/2026 - Tickeron - Stocks
Agenus (AGEN, $3.12) Aroon Indicator entered a Downtrend on December 30, 2025.
12/31/2025 - Tickeron - Stocks
Agenus (AGEN, $3.19) Aroon Indicator entered a Downtrend on December 29, 2025.
12/30/2025 - Tickeron - Stocks
Agenus Inc. (NASDAQ:AGEN) Short Interest Up 56.5% in December
12/30/2025 - Ticker Report
Agenus files to sell 1.32M shares of common stock or holders
12/29/2025 - The Fly
Short Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 56.5%
12/29/2025 - MarketBeat
Agenus (AGEN, $3.31) Stochastic Oscillator left the oversold zone on December 26, 2025
12/27/2025 - Tickeron - Stocks
Agenus (AGEN, $3.31) Stochastic Oscillator left the oversold zone on December 23, 2025
12/24/2025 - Tickeron - Stocks
Agenus (AGEN, $3.31) RSI Indicator left the oversold zone on December 23, 2025
12/24/2025 - Tickeron - Stocks
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory ...
12/23/2025 - GuruFocus
Agenus (AGEN, $3.51) RSI Indicator left the oversold zone on December 22, 2025
12/23/2025 - Tickeron - Stocks
Agenus publishes C-800-01 trial data in The Journal for ImmunoTherapy of Cancer
12/23/2025 - The Fly
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
12/23/2025 - Business Wire
Agenus (AGEN, $3.51) Aroon Indicator entered a Downtrend on December 18, 2025.
12/19/2025 - Tickeron - Technical Analysis
Agenus (AGEN, $3.59) RSI Indicator left the oversold zone on December 17, 2025
12/18/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$106.83M
EBITDA (TTM)
-$50.28M
EBIT (TTM)
-$62.94M
Net Income (TTM)
-$35.17M
Balance Sheet
Total Assets (Q)
$233.89M
Total Debt (Q)
$46.15M
Total Liabilities (Q)
$514.76M
Book Value Per Share (Q)
-$8.35
Cash Flow
Cash from Operations (TTM)
-$89.23M
Cash from Investing (TTM)
$393.00K
Cash from Financing (TTM)
$45.59M
Net Change in Cash (TTM)
-$43.25M
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
3.12
7-Day Total Return
11.78%
30-Day Total Return
-12.32%
60-Day Total Return
-6.80%
90-Day Total Return
-12.94%
Year to Date Total Return
14.55%
1-Year Total Return
4.23%
2-Year Total Return
-75.68%
3-Year Total Return
-93.95%
5-Year Total Return
-96.28%
52-week Low
Apr 07, 2025 - $1.38
52-week High
Jul 11, 2025 - $7.34
Valuation
Market Cap
$118.01M - Micro Cap
Enterprise Value
$153.97M
Price/Sales (TTM)
1.07
Price/Book (Q)
-0.42
Dividends and Shares
Shares Outstanding
32.86M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.agenusbio.com
Phone Number
781 674 4400
Address
3 Forbes Road
Lexington, MA 02421-7305
Country
United States
Year Founded
1994
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally... more
NASDAQ 01/07/2026 4:00PM Eastern Quotes delayed